Opaleye Management Inc., 10% Owner at Grace Therapeutics, Inc. (GRCE), bought 14,632 shares at $2.02 ($30K) on 2026-10-08, disclosed to the SEC on 2026-10-13.
Open-market purchase of $30k GRCE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.02 | 2,077 | $4K | 14.1% |
| 2 | $2.04 | 5,340 | $11K | 36.8% |
| 3 | $2.02 | 7,215 | $15K | 49.1% |
| Total | $2.03 avg | 14,632 | $30K | 100% |
| Filing → |
| GRCE | BUY | 2026-10-01 | $16K | — | Filing → |
| GRCE | BUY | 2026-09-23 | $32K | — | Filing → |
| ACOG | BUY | 2026-09-16 | $1.1M | — | Filing → |